Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs

ConditionObesity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorInstitut Investigacio Sanitaria Pere Virgili

About this trial

The main aim of the present study is to evaluate the effectiveness of two dietary protocols: Daily Caloric Restriction (DCR) and Early Time-Restricted Feeding + DCR (eTRE) on metabolic homeostasis and the influence of circulating extracellular vesicles (EVs) as inter-organ communication elements in obese patients.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age between 18 and 70 years old.

BMI ranges between 27 and 40 kg/ m2.

Absence of underlying pathology in medical and physical examination, except for those related to excess weight.

Signature of the informed consent for participation in the study.

Disqualifiers

Serious systemic disease not related to obesity, such as cancer, kidney or severe liver disease.

Systemic diseases with intrinsic inflammatory activity (autoimmune diseases such as rheumatoid arthritis and asthma).

Pregnancy and lactation.

Vegetarians or subjects subjected to an irregular diet.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Active Comparator: Continuous calorie restriction

    Behavioral

    Individualized continuous calorie restriction diet based on healthy Mediterranean diet recommendations aiming to achieve at least a 5% weight loss at the end of the intervention

  • eTRE

    Behavioral

    early (morning) time-restricted eating pluss individualized continuous calorie restriction diet based on healthy Mediterranean diet recommendations aiming to achieve at least a 5% weight loss at the end of the intervention

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Continuous caloric restrictionActive comparator 1 intervention
Group B: eTREExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Anthropometric measurements (I)

Changes in weight (kg)

Time frame
Before and after (12 weeks) of the intervention
2

Anthropometric measurements (II)

Changes in body mass index (kg/m\^2);

Time frame
Before and after (12 weeks) of the intervention
3

Anthropometric measurements (III)

Changes waist circumference (cm)

Time frame
Before and after (12 weeks) of the intervention
4

Anthropometric measurements (IV)

Changes hip circumference (cm)

Time frame
Before and after (12 weeks) of the intervention

Secondary outcomes

1

Gut and host microbiota-derived metabolites (I)

Changes in circulating short-chain fatty acids levels \[µM\]; assesed by Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS)

Time frame
Before and after (12 weeks) of the intervention
2

Gut and host microbiota-derived metabolites (II)

Changes in circulating bile acids levels \[nM\]; Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Time frame
Before and after (12 weeks) of the intervention
3

Gut and host microbiota-derived metabolites (III)

Changes in circulating succinate levels \[µM\]; assesed by EnzyChrom™ Succinate Assay Kit

Time frame
Before and after (12 weeks) of the intervention
4

Entero-endocrine incretin hormones (I)

Changes in post-prandial response to a meal-tolerance test in serum levels of glucose \[mg/dL\]; assesed by ELISA kit

Time frame
Before and after (12 weeks) of the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.